| Drug Name | Tekam (Midazolam Hydrochloride) |
|---|---|
| Drug Class |
Anti-convulsant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Safety communication regarding repeated or lengthy use of general anesthetic and sedation drugs during surgeries or procedures in children younger than 3 years or in pregnant women during their third trimester . |
| Dear Healthcare provider letter DHPC |
|